Aripiprazole Added on Methylphenidate in the Treatment of Youths With Comorbid ADHD and DMDD

Trial Profile

Aripiprazole Added on Methylphenidate in the Treatment of Youths With Comorbid ADHD and DMDD

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Dec 2017

At a glance

  • Drugs Aripiprazole (Primary) ; Methylphenidate (Primary)
  • Indications Attention deficit and disruptive behaviour disorders
  • Focus Therapeutic Use
  • Acronyms AAOFDIYWA
  • Most Recent Events

    • 05 Dec 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top